Israeli Scientist Develops Immunotherapy to Slow Aging

Israeli researchers led by Prof. Michal Schwartz are developing immunotherapy to boost the immune system, aiming to slow aging and neurodegenerative diseases.
Israeli Scientist Develops Immunotherapy to Slow Aging Israeli Scientist Develops Immunotherapy to Slow Aging
Photo: Prof. Michal Schwartz / Weizmann Institute of Science.

Israeli scientist Michal Schwartz and her team are close to creating an innovative immunotherapy treatment to boost the immune system and slow aging. Their work, recently published in the journal Neuron, is set to transform the understanding of aging and brain health.

Schwartz, a 2023 Israel Prize winner, has spent 27 years researching the immune system’s role in maintaining the brain. Her groundbreaking findings show that the immune system is crucial for the brain’s lifelong function. She believes enhancing specific immune cells could slow aging in both the brain and the body.

“Boosting the immune system for the brain will also benefit the entire body,” Schwartz said during a teleconference.

In 1998, Schwartz challenged the belief that the brain operates independently of the immune system. At the time, scientists thought immune activity in the brain caused harm. Schwartz questioned this idea, suspecting a deeper connection.

Her persistence paid off. After years of skepticism, the scientific community began to acknowledge her findings. Today, her work shows that aging weakens the immune system, contributing to brain aging and neurodegenerative diseases like Alzheimer’s.

Schwartz’s research suggests that targeting the immune system—not the brain directly—could prevent or slow brain deterioration.

Michal Schwartz: Pioneering Treatments

Schwartz co-founded ImmunoBrain, which is testing an antibody treatment for neurodegenerative diseases, including Alzheimer’s. Antibodies are immune proteins that neutralize harmful substances like viruses and bacteria. This therapy could pave the way for anti-aging immune treatments.

Advancements in this field are rapid. Schwartz predicts significant breakthroughs in the next two to three years

Combating Aging at the Cellular Level

Aging triggers changes in the immune system, including increased inflammation—known as “inflammaging”—and the buildup of senescent or “zombie” cells. These cells, while inactive, spread inflammation and accelerate aging.

Scientists are exploring drugs called senolytics, which target and eliminate these harmful cells. In tests on aged mice, senolytic drugs improved cognitive function. Schwartz believes these treatments could eventually delay the effects of aging in humans.

Practical Tips for Brain Health

While her research focuses on immunotherapy, Schwartz emphasizes the role of lifestyle in brain health. Exercise reduces inflammation, enhances brain function, and slows aging. A balanced, low-calorie diet can also combat inflammation and improve blood flow, preserving memory and learning abilities.

Certain foods naturally contain Quercetin, a senolytic compound. It is found in green tea, berries, apples, onions, and citrus fruits. These dietary habits, combined with regular sleep and stress reduction, further support brain health by boosting the immune system.

Schwartz herself practices what she preaches—although with some exceptions. “I’m stressed, and my nutrition isn’t perfect, but I exercise a lot,” she admitted. Her family and her work remain her greatest sources of joy.

A Hopeful Future

Schwartz remains optimistic. Her ultimate goal is to prevent immune system decline entirely. If successful, her team’s treatments could restore and enhance immune function, offering a new frontier in aging and health.

“We aim to prevent immune system deterioration,” Schwartz said. “With this, we’ll be able to restore it and slow the aging process.”

This version is concise, active, and integrates transition words to improve flow while retaining the article’s core message.

Read more Longevity news.

Add a comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Keep Up to Date with the Most Important News

By pressing the Subscribe button, you confirm that you have read and are agreeing to our Privacy Policy and Terms of Use